Have you developed – or are you looking to create – a healthcare solution based on digital technology? If so, you stand the chance of winning £20,000 and mentoring opportunities from MedImmune, the global biologics research and development arm of AstraZeneca.
Older people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. The lessons learned there will be critical as the population grows older in many other markets.
Jarrod Borkat of MedImmune says what would help MedImmune would be other large biotech companies located in Montgomery County. Although he expects his company would lose talent, it would be a net gain.
The Maryland Department of Assessments and Taxation unveiled a new website Monday designed to help small business owners and entrepreneurs plan, start, manage and grow their businesses.
The year 2017 marked yet another exciting period of innovation and growth for the University of Maryland (UMD) research community, with over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history in total of $219.5 million from the A. James and Alice B. Clark Foundation. Researchers broke barriers in fields related to agriculture, information management, biotechnology, and energy, making discoveries and inventing technologies that have the potential to make positive impacts on the planet and on people’s lives around the globe.
Join ISPE Chesapeake Bay Area Chapter, Maryland Tech Council, BioHealth Innovation and ByteGrid for a one day Life Sciences Cloud & Infrastructure Conference.
Listen to speakers, including Krishna Ghosh, Ph. D., Senior Policy Advisor at the Food and Drug Administration, and the co-chairs of the GAMP Cloud Special Interest Group and get a behind-the-scenes data center tour of ByteGrid’s flagship Silver Spring facility.
You’ll also get valuable insights into cloud adoption in the regulated Life Sciences industry, hear about updates to the revised ISPE GAMP Good Practice Guide on IT Infrastructure and much more!
The agenda and speakers are listed here: https://hubs.ly/H0b3TKs0
The Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) solicitation is a companion SBIR funding opportunity announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention.
TEDCO, Maryland’s economic engine for technology companies, inducts ClearMask into its mdPACE program to assist in bringing its life-changing innovation to market. Baltimore-based, ClearMask LLC is the developer of the country’s first, full-face transparent surgical mask designed to help healthcare entities reduce medical errors caused by miscommunication and provide a better experience for deaf patients and other patient groups who heavily rely on visual cues, including children, limited English proficiency patients, and immunosuppressed patients who cannot see the smiles of their loved ones and care team.
23andMe, Inc., the leading personal genetics company, today received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.
Surgeons trying a new way to save the life of a baby born with half a heart stood over her open chest and waited for the FedEx box.
